Who Sells GLP-1 Drugs in the UK? (October 2026)

01 · The short answer

Who sells GLP-1 drugs in the UK?

GLP-1 drugs are sold in the UK by registered pharmacies and supplied by NHS services, and only against a prescription. That covers injections such as Mounjaro and Wegovy and the newer tablets. There is no legal over-the-counter route for any of them.

Mounjaro (tirzepatide) is made by Eli Lilly and is licensed in the UK for weight management in adults and for type 2 diabetes.¹ It is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.¹ Wegovy (semaglutide) is made by Novo Nordisk and follows the same rule.

Cost-focused readers can also look at where Mounjaro is cheapest and available.

02 · Comparison

The types of seller compared

The first four rows are legitimate. The last two are not, and the difference is not only legal: with unregulated supply you cannot know what is in the product.

03 · What to do next

Choosing where to get treatment

Start by deciding whether you meet the licensed criteria, then pick a regulated route. Our weight loss clinic explains how a consultation works. If you are leaning towards injections, the Mounjaro pen page shows live prices and starts the free consultation. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price.

Related guide: Who sells mounjaro.

04 · Makers versus sellers

Manufacturers are not the people who sell to you

The company that makes a GLP-1 medicine is rarely the one that sells it to you. Eli Lilly makes Mounjaro and Foundayo. Novo Nordisk makes Wegovy injections and Wegovy tablets. Both supply wholesalers, pharmacies and the NHS.

That distinction matters when you read adverts. A site that claims to be 'the manufacturer' or to sell 'direct from the lab' to individuals without a prescription is not describing a normal UK supply chain. A pharmacy sourcing from the maker's authorised UK distribution is. We supply Mounjaro through official LillyDirect supply, which means genuine KwikPens direct from Eli Lilly's UK distribution.

If you are curious about the companies behind these medicines, see our explainers on which companies make GLP-1 drugs, how manufacturing is organised and who developed the science. For the ownership question there is a separate page on who owns the GLP-1 medicines.

The injectables differ in what they are. Mounjaro is a once-weekly injectable made by Eli Lilly and comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

05 · Licensed GLP-1 tablets

Who sells GLP-1 pills?

GLP-1 pills are sold by the same regulated routes as injections: pharmacies and NHS services, on prescription. Two are now licensed in the UK for weight management, and they are different medicines from Mounjaro.

There is no tablet form of Mounjaro — tirzepatide is injection-only in the UK. Two GLP-1 weight-loss tablets are now licensed in the UK: Wegovy tablets (oral semaglutide, made by Novo Nordisk), approved by the MHRA in June 2026, and Foundayo (orforglipron, made by Eli Lilly), approved in August 2026.²⁰²¹ Both are prescription-only.

Wegovy tablets. They contain semaglutide, the same active ingredient as the Wegovy injection, taken as one tablet once a day. They are licensed for weight management in adults with a BMI of 30 or above, or 27 to under 30 with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity.²⁰ The tablet must be taken on an empty stomach after fasting for at least 8 hours, swallowed whole with a sip of water (up to half a glass, about 120ml), and you then wait at least 30 minutes before eating, drinking or taking other tablets.²⁰ You can see current prices on the Wegovy pill page.

Foundayo. It contains orforglipron, a once-daily GLP-1 tablet made by Eli Lilly. Unlike Wegovy tablets it can be taken at any time of day, with or without food and without water restrictions.²¹ Prices and consultation are on the Foundayo page.

What the tablet trials showed

In the OASIS 4 trial, adults taking semaglutide 25mg tablets for 64 weeks lost on average 13.6% of their body weight, compared with 2.2% on placebo.²² In the ATTAIN-1 trial of 3,127 adults without type 2 diabetes, people taking the highest dose of orforglipron for 72 weeks lost on average 12.4% of their body weight, compared with 0.9% on placebo.²³ Individual results vary.

Mounjaro is a once-weekly injection; Wegovy tablets and Foundayo are once-daily tablets. No trial has compared Mounjaro directly with either tablet, so results from separate trials — with different people, durations and doses — should not be set against each other as if they were head to head.²⁰ A prescriber will check which option is suitable for your health, your other medicines and your routine.

The most common side effects of the tablets are digestive, such as nausea, constipation, diarrhoea, vomiting, indigestion and stomach pain.²¹²²

06 · NHS supply

NHS access to GLP-1 drugs

The NHS is a seller of sorts: it supplies GLP-1 medicines through GPs and specialist services, at no charge beyond any normal prescription arrangements. Mounjaro is available on the NHS, but access is being phased in over several years.⁴

NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

NHS access to Wegovy runs through specialist weight-management services; ask your GP. Whether you go NHS or private, the prescribing logic is the same: a clinician assesses whether the medicine is suitable for you.

07 · Spotting unsafe sellers

How to tell a legitimate seller from a scam

A legitimate seller will always want to assess you first. Anyone offering to supply without a consultation or prescription is breaking the rules, whatever the website looks like. Counterfeit and unlicensed products are a known risk, and the MHRA publishes counterfeit medicine alerts.⁷

Use this checklist before you pay anyone:

• Check the register. A real UK pharmacy has a GPhC registration number you can look up on the public register. Ours is GPhC 9012878.
• Look for a consultation. A questionnaire reviewed by a GPhC-registered prescriber, not an instant checkout.
• Beware of dramatic weight-loss claims. Promises of specific results are a warning sign.
• Avoid 'research' products. Unlicensed 'research' peptides, such as retatrutide, which has no UK licence, and compounded copies have no safety data and no regulated supply chain.⁷
• Check how it is packed. Genuine pens arrive in temperature-controlled packaging from a pharmacy, not in an unmarked envelope.

If you ever have a side effect from any medicine, you can report it through the MHRA Yellow Card scheme.¹⁹

08 · Supplements and 'natural GLP-1'

Do supplement sellers count?

No. 'Natural GLP-1' supplements (such as berberine) are not medicines, are not regulated for this use and have no comparable trial evidence. They are low-cost supplements with no clinical oversight, and their cheapness is a reason for caution, not a bargain. Dosing is not standardised.

Other licensed options exist beyond GLP-1 drugs. Orlistat (tablet) blocks some dietary fat absorption and produces smaller average losses, and Wegovy and Saxenda (liraglutide) are other licensed injectables. Liraglutide is supplied at 6mg/ml and is a daily injection, unlike once-weekly Mounjaro and Wegovy.

Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. A regulated UK pharmacy will not supply Ozempic for weight loss. The licensed weight-management options are Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4mg).

09 · Cost and comparing sellers

How much do GLP-1 drugs cost from different sellers?

Private prices vary by medicine, dose and pharmacy. Across the UK pharmacies we track, Mounjaro pens range from £143.96 to £339.00 per month, and the smallest and largest gap between providers for the same dose runs from £27 to £41 (checked 11 October 2026). Starting 2.5mg pens range from £143.96 to £179.99.

Our own prices are shown live. A new customer gets £40 off their first order at any dose with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). Wegovy's first pen is £99.99 as a first-order price; see the Wegovy pen page for current details.

When you compare sellers, look beyond the headline price. Ask whether the consultation is free, whether delivery is included and whether ongoing reviews are part of the service. Our consultation is free, the price shown is the price paid, and delivery is free next-day tracked in temperature-controlled packaging (Saturday delivery £14.99). Payment options include Visa/Mastercard and Klarna, with no subscriptions.

Which medicine is the seller offering?

In the first large head-to-head trial (SURMOUNT-5), adults on tirzepatide lost on average 20.2% of body weight over 72 weeks versus 13.7% on semaglutide 2.4mg (Wegovy).¹⁵ Both are effective, licensed treatments; which suits you depends on your health profile, tolerance and prescriber advice, not the headline number alone.¹⁵ In the STEP 1 trial, adults on semaglutide 2.4mg (Wegovy) lost on average 14.9% of body weight over 68 weeks, compared with 2.4% on placebo.⁹

10 · Who should not buy

Who should not buy a GLP-1 drug

Some people should not use these medicines, and a good seller will screen for that. You should not take Mounjaro if you are allergic to tirzepatide or any of its ingredients. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive.¹ If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.¹

Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ This applies to the pill only — implants, coils and injections are unaffected.¹

Mounjaro is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

11 · How ordering works

How ordering works with us

Ordering from a regulated pharmacy is a short, structured process. This is how it works at EverydayMeds, a full UK online pharmacy covering weight loss, sexual health, hair loss and acid reflux.

• Free online consultation. A short health questionnaire, with no charge and no obligation.
• Prescriber review. Your answers are reviewed by a GPhC-registered prescriber. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and delivery. Our registered pharmacy dispenses your order, with same-day dispatch when ordered by 3pm and free next-day tracked delivery.

Repeat orders re-check suitability, and there is no auto-shipping. Ongoing monthly reviews, dose-titration and follow-up assessments are handled by the prescribing team, with side-effect support. Needles, a sharps bin and injection guidance come with every order. The free GLPTrackr app helps you track your journey.